loading

Zentalis Pharmaceuticals Inc Azioni (ZNTL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Operating Expenses
17.27%
44.39
37.85 37.39 33.73 36.06
Operating Income/Loss
17.27%
-44.39
-37.85 -37.39 -33.73 -36.06
Income/Loss From Continuing Operations Before Tax
19.63%
-42.15
-35.23 -34.77 -26.69 -26.87
Income Tax Expense/Benefit
15.00%
0.138
0.12 0.442 - -
Net Income/Loss
19.61%
-42.29
-35.35 -35.22 -26.69 -26.87
Basic Average Shares
1.51%
71.33
70.26 - 72.14 71.99
Diluted Average Shares
1.51%
71.33
70.26 - 72.14 71.99
Basic Earnings Per Share
18.00%
-0.59
-0.50 - -0.37 -0.37
Diluted Earnings Per Share
18.00%
-0.59
-0.50 - -0.37 -0.37
$10.98
price down icon 7.34%
$7.84
price down icon 3.21%
$8.055
price down icon 3.88%
$5.8455
price down icon 0.25%
$13.68
price down icon 5.66%
WVE WVE
$3.17
price down icon 5.37%
Capitalizzazione:     |  Volume (24 ore):